For the quarter ending 2025-12-31, IREN had $2,228,298K increase in cash & cash equivalents over the period. -$468,043K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Total segment and consolidated revenue | 184,692 | 240,295 | - |
| Total segment and consolidated cost of revenue | 65,763 | 80,673 | - |
| Segment gross profit (loss) | 278,551 | - | - |
| Selling, general and administrative expenses | 100,755 | 138,359 | - |
| Depreciation and amortization | 99,176 | 85,226 | - |
| Impairment of assets | 31,755 | 16,257 | - |
| Gain (loss) on disposal of property, plant and equipment | 7 | -13 | - |
| Other operating expenses | 5,468 | 0 | - |
| Other operating income | 1,815 | 3,828 | - |
| Finance expense | 10,668 | 9,280 | - |
| Interest income | 15,775 | 7,128 | - |
| Increase (decrease) in fair value of assets held for sale | -6,449 | - | - |
| Realized gain (loss) on financial instruments | -2,910 | -5,756 | - |
| Unrealized gain (loss) on financial instruments | -107,351 | 664,993 | - |
| Debt conversion inducement expense | 111,799 | - | - |
| Foreign exchange gain (loss) | 1,878 | -5,382 | - |
| Other non-operating income | 0 | 0 | - |
| Income tax (expense) benefit | -182,520 | 190,687 | - |
| Net income (loss) | -155,407 | 384,611 | 86,941 |
| Depreciation and amortization | 99,176 | 85,226 | 181,136 |
| Impairment of assets | 31,755 | 16,257 | 7,223 |
| Change in fair value of assets held for sale | - | 0 | 2,160 |
| Other non-operating income | - | - | 0 |
| Change in fair value of assets held for sale | -6,449 | - | - |
| Realized (gain) loss on financial instruments | -2,910 | -5,756 | -4,215 |
| Unrealized (gain) loss on financial instruments | -107,351 | 664,993 | 77,518 |
| Debt conversion inducement expense | 111,799 | - | - |
| Other (income) expense | 0 | 0 | -11,811 |
| Other finance expense | - | - | 586 |
| (gain) loss on disposal of subsidiaries | - | - | 0 |
| (gain) loss on disposal of property, plant and equipment | 7 | -13 | 4,002 |
| Foreign exchange loss (gain) | -5,513 | -2,201 | -3,821 |
| Gain on partial extinguishment of financial liabilities | - | - | 9,093 |
| Accrued interest related to hardware financing | - | - | 0 |
| Stock-based compensation expense | 58,231 | 72,405 | 42,642 |
| Amortization of debt issuance costs | 2,041 | 1,340 | 1,400 |
| Accounts receivable and other receivables | 11,908 | 13,090 | 9,656 |
| Other assets | -35 | -169 | - |
| Financial asset, current | 0 | 0 | -6,530 |
| Tax related receivables | - | -2,581 | 2,581 |
| Tax related liabilities | -180,297 | 187,943 | 4,911 |
| Accounts payable and accrued expenses | -12,505 | 3,489 | 16,689 |
| Other liabilities | -13,014 | 48,679 | 2,718 |
| Deferred revenue | 23,284 | 22,457 | -1,674 |
| Prepayments and deposits | 1,089 | 12,647 | 22,227 |
| Operating lease liabilities | -85 | -44 | -146 |
| Net cash from (used in) operating activities | 71,651 | 142,353 | 245,886 |
| Payments for property, plant and equipment net of computer hardware | 539,694 | 180,307 | 573,456 |
| Payments for computer hardware prepayments | - | 100,304 | 799,171 |
| Payments for computer hardware | 279,708 | - | - |
| Repayments/(advancement) of loan proceeds | - | - | 0 |
| Payments for intangible assets | 107,573 | - | - |
| Payments for other prepayments and other assets | - | 266 | 19,502 |
| Payments for other prepayments and deposits | 14,362 | - | - |
| Proceeds from disposal of property, plant and equipment | 0 | 0 | 11,172 |
| Deconsolidation of non-recourse spvs | - | - | 0 |
| Proceeds from release of deposits | - | - | 470 |
| Deposits paid for right-of-use assets | 10,184 | - | - |
| Net cash from (used in) investing activities | -850,951 | -280,877 | -1,380,487 |
| Payments of offering costs for committed equity facility and for the issuance of common stock at the market offering-Committed Equity Facility | - | - | 0 |
| Payment of offering costs for the issuance of ordinary shares | 0 | 18,495 | - |
| Payments of offering costs for committed equity facility and for the issuance of common stock at the market offering-At The Market Facility | - | - | 1,069 |
| Proceeds from the issuance of ordinary shares | 1,632,427 | 618,355 | - |
| Repayment of borrowings | - | - | 0 |
| Payment for induced conversion of convertible notes | 1,623,484 | - | - |
| Proceeds from loan funded shares | 101 | 557 | 876 |
| Proceeds from exercise of options | 0 | 6,597 | - |
| Proceeds from convertible notes | 3,299,555 | - | 701,211 |
| Payment of capped call transactions | 252,252 | - | - |
| Payment of borrowing transaction costs | 48,749 | 877 | 8,088 |
| Proceeds from committed equity facility and from the issuance of common stock at the market offering-Committed Equity Facility | - | - | 0 |
| Proceeds from committed equity facility and from the issuance of common stock at the market offering-At The Market Facility | - | - | 601,805 |
| Net cash from (used in) financing activities | 3,007,598 | 606,137 | 1,294,735 |
| Net increase (decrease) in cash and cash equivalents | 2,228,298 | 467,613 | 160,134 |
| Cash and cash equivalents at beginning of period | 1,032,263 | 564,526 | 404,601 |
| Effect of exchange rate changes on cash | 28 | 124 | -209 |
| Cash and cash equivalents at end of period | 3,260,589 | 1,032,263 | 564,526 |
IREN Ltd (IREN)
IREN Ltd (IREN)